Compare Segar Kumala Indonesia Tbk (BUAH) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Segar Kumala Indonesia Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Segar Kumala Indonesia Tbk trades at Rp520 (market cap 1.04T), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B). The key difference: Segar Kumala Indonesia Tbk is far larger — about 6.2× Brigit Biofarmaka Teknologi Tbk.'s market cap. Which is the better fit depends on your goals.
| BUAH | OBAT | |
|---|---|---|
Market Cap | 1.04T | 167.37B |
Indicative Equilibrium Price | — | 246 |
Indicative Equilibrium Volume | — | 24 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Segar Kumala Indonesia Tbk
PT Segar Kumala Indonesia Tbk (“the Company”) was established based on Notarial Deed of P. Sutrisno A. Tampubolon, No. 14 dated June 10, 2017.
Read more on BUAH →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
